Clicky

Merck & Company, Inc.(MRK)

Description: Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.


Keywords: Medicine Life Sciences S&P 500 Pharmaceutical Products Medication Diabetes Infectious Diseases Antibiotics Cac 40 Health Products Ophthalmology Vaccines Obesity IBD 50 Lotion Respiratory Diseases ETN Animal Health Products Dow Jones Component Animal Health Fertility Health Solutions Amines Over The Counter Products Constipation Food Chain High Blood Pressure Foot Care Products Drug Wholesalers Health Maintenance Organizations Occasional Constipation Biologic Therapies Human Health Pharmaceutical Products Sun Care Products

Home Page: www.merck.com

MRK Technical Analysis

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
Phone: 908 740 4000


Officers

Name Title
Mr. Robert M. Davis J.D. CEO & Chairman
Ms. Caroline Litchfield Exec. VP & CFO
Mr. Richard R. DeLuca Jr. Exec. VP & Pres of Merck Animal Health
Dr. Dean Y. Li M.D., Ph.D. Exec. VP & Pres of Merck Research Laboratories
Mr. David Michael Williams Exec. VP and Chief Information & Digital Officer
Mr. Peter Dannenbaum VP of Investor Relations
Ms. Jennifer L. Zachary Exec. VP & Gen. Counsel
Lisa LeCointe-Cephas Sr. VP and Chief Ethics & Compliance Officer
Ms. Jennifer Mauer VP of Global Communications
Ms. Cristal N. Downing Exec. VP and Chief Communications & Public Affairs Officer

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 14.7493
Trailing PE: 18.3765
Price-to-Book MRQ: 6.3616
Price-to-Sales TTM: 4.7132
IPO Date: 1978-01-13
Fiscal Year End: December
Full Time Employees: 67000
Back to stocks